We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.54M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$2.12M |
| 5 |
NVIDIA
NVDA
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$4.62M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$825K |
| 4 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$562K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.18% |
| 2 | Technology | 15.3% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Allegion
ALLE
$14.4B
| $68.9K | 0.01% |
574
+11
| +2% | +$1.2K |
|
602
Owens Corning
OC
$12.4B
| $68.6K | 0.01% |
526
+86
| +20% | +$9.42K |
|
603
W.W. Grainger
GWW
$60.2B
| $68.6K | 0.01% |
87
-1
| -1% | -$689 |
|
|
CNH
604
CNH Industrial
CNH
$17.5B
| $68.6K | 0.01% |
4,764
-7
| -0.1% | -$98 |
|
|
ELP
605
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $68.5K | 0.01% |
9,948
+173
| +2% | +$1.05K |
|
606
Omnicell
OMCL
$1.68B
| $68.5K | 0.01% |
930
| – | – |
|
607
ORIX
IX
$43.5B
| $68.4K | 0.01% |
3,750
| – | – |
|
608
James Hardie Industries
JHX
$17.5B
| $68.4K | 0.01% |
2,543
+155
| +6% | +$3.74K |
|
609
Aflac
AFL
$62.6B
| $67.9K | 0.01% |
973
+80
| +9% | +$5.35K |
|
|
AKRO
610
DELISTED
Akero Therapeutics
AKRO
| $67.9K | 0.01% |
1,454
| – | – |
|
|
ANSS
611
DELISTED
Ansys
ANSS
| $67.4K | 0.01% |
204
| – | – |
|
612
Halozyme
HALO
$12.2B
| $67.3K | 0.01% |
1,865
+308
| +20% | +$10.5K |
|
613
Warner Bros
WBD
$67.1B
| $66.2K | 0.01% |
5,280
-2,824
| -35% | -$36.6K |
|
614
CoStar Group
CSGP
$12.3B
| $65.9K | 0.01% |
740
+234
| +46% | +$18.1K |
|
615
Tanger
SKT
$4.52B
| $65.7K | 0.01% |
2,979
| – | – |
|
616
McCormick & Company Non-Voting
MKC
$14.2B
| $65.7K | 0.01% |
753
+69
| +10% | +$6.1K |
|
617
Inspire Medical Systems
INSP
$1.74B
| $65.6K | 0.01% |
202
+1
| +0.5% | +$286 |
|
618
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
| $65.5K | 0.01% |
8,530
+19
| +0.2% | +$136 |
|
619
Graco
GGG
$13.5B
| $64.7K | 0.01% |
749
+29
| +4% | +$2.25K |
|
|
DFS
620
DELISTED
Discover Financial Services
DFS
| $64.2K | 0.01% |
549
+41
| +8% | +$4.3K |
|
621
Ball Corp
BALL
$16.8B
| $64K | 0.01% |
1,099
-22
| -2% | -$1.19K |
|
622
EQT Corp
EQT
$32.3B
| $64K | 0.01% |
1,555
+176
| +13% | +$6.22K |
|
623
NXP Semiconductors
NXPI
$60.4B
| $63.9K | 0.01% |
312
-48
| -13% | -$8.53K |
|
624
The 3D Printing ETF
PRNT
$65M
| $63.3K | 0.01% |
2,700
| – | – |
|
625
Simply Good Foods
SMPL
$982M
| $63.3K | 0.01% |
1,729
| – | – |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.
- Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
- Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
- Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
- Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
- Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
- Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.
Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.